Dealcast: The M&A Podcast

Jan 29 2025 213 ep. 13 mins 33

Dealcast: The M&A Podcast artwork

Dealcast: The M&A Podcast Weekly podcast from the Mergermarket editorial team covering M&A, ECM and activism presented by Mergermarket and SS&C Intralinks.

Copy RSS

Subscribe on Podcast Addict

13: Dealcast: Vertical farming grows up

Nov 13 2019 9 mins

Could tomorrow’s groceries come from a lab? Today’s vertical-farming startups aim to grow food in tightly controlled indoor stacks, solving a host of problems – blight, water wastage and a shortage of land – at once. Leading the way are such firms as the UK’s Intelligent Growth Solutions, Belgium’s Urban Crop Solutions and Italy’s Planet Farms, all of which featured i

12: Dealcast: Allergan reaction

Aug 09 2019 13 mins

The European Commission (EC) is reviewing AbbVie’s [NYSE:ABBV] proposed acquisition of Botox producer Allergan [NYSE:AGN]. The merging parties have already pledged to divest such products as brazikumab, a drug under development for ulcerative colitis and Crohn’s disease, and Zenpep (pancrelipase), which treats a pancreatic disorder, but the EC may want more changes if it is to

11: Dealcast: KKR’s play for Axel Springer

Jun 20 2019 10 mins

German media conglomerate Axel Springer [ETR:SPR] has caught the eye of KKR [NYSE:KKR]. With Axel Springer’s founding family supporting its bid, KKR has an easier route towards taking the target off the market. Activistmonitor editor William Mace and Mergermarket’s resident DACH expert Emma-Victoria Farr joined us to discuss what the deal could mean for Axel Springer’s future

10: Dealreporter Asia: AGL Energy's offer for Vocus, Healius' investing in Japan and Kuyushu Railway Co's AGM

Jun 14 2019 15 mins

This 15-minute podcast discusses Asian deals and events of interest to hedge funds and other professional investors.

9: Dealcast Asia: Melco buys Crown stake, Qunar's surprise ruling

May 31 2019 18 mins

In this weekly edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Anette Jönsson discuss key developments on several Asian situations, including comments by Malaysia’s prime minister indicating Australian rare earth producer Lynas [ASX:LYC] will be allowed to continue operating in the Southeast Asian country; and the potential implications of casino tycoon Jam

8: Tipping Point: Deal Terms

Oct 13 2020 27 mins

Seyfarth’s Paul Pryzant and SRS Acquiom's Chris Letang join Tom Cane to discuss how the shift from a seller’s to a buyer’s M&A market this year has impacted the deal terms being agreed in the mid-market, from an increase in earn-outs and termination fees to the impact of the pandemic on reps and warranties. Paul and Chris also discuss how technology is changing the due di

8: Dealcast: Tech listings go awry

May 29 2019 9 mins

Wobbly tech-sector IPOs, including those of Uber [NYSE:UBER] and Finablr [LON:FIN], have dampened the mood for ECM. Dealreporter ECM editor Gustav Sandstrom joined us to discuss how these high-profile fumbles could affect similar listings ahead this year.

The European SPACs boom and SS&C Intralinks Deal Flow Predictor

Mar 30 2021 20 mins

Mergermarket's ECM Editor, Sofia Cerqueira, joins Julie-Anna to discuss the global SPACs boom and how it's picking up pace in Europe. Julie-Anna is also joined by Co-Heads of SS&C Intralinks, Ken Bisconti and Bob Petrocchi, to discuss the latest Deal Flow Predictor.

7: Dealcast: Covid-19 and healthcare M&A

Apr 29 2020 18 mins

No sector is closer than healthcare to the front-lines of the covid-19 pandemic. Not only is the pandemic shaking up businesses in the sector, it is creating opportunities for dealmaking. Indeed, Thermo Fisher’s [NYSE:TMO] proposed takeover of diagnostics firm Qiagen [NYSE:QGEN] shows how the crisis can make the case for M&A. In this week’s podcast, Mergermarket healthcare

7: Dealcast Asia: SAMR leadership change, the latest on Lynas and upcoming deals

May 24 2019 12 mins

In this inaugural edition of Dealreporter Asia Pacific’s podcast, Stephanie Hanna and Ed Vinales discuss the appointment of a new head of China’s State Administration for Market Regulation (SAMR), and how the US-China trade dispute is impacting Wesfarmer’s hostile bid for rare-earth miner Lynas. Other situations covered include the hairy privatisation of Hong Kong’s Harbin